University of Ioannina
Μοριακοί μηχανισμοί του VEGF στην αγγειοποίηση και εφαρμογές στην αναγεννητική ιατρική
Abstract
dc:descriptionRegenerative Medicine develops cell therapies using the regenerative capacity of human embryonic stem cells (hESC) and their reprogrammed equivalents (hiPSC). It achieves this with the help of tissue engineering by creating optimal microenvironments for the growth and differentiation of stem cells and the creation of implantable tissue structures with the correct spatial organization. The availability of blood vessels is an important requirement for the viability and function of the implantable tissue structure supporting its in vivo development. Tissue regeneration above 100-200μm exceeds the ability to provide nutrients and remove waste by diffusion and requires the creation of a vascular network. Unfortunately, the host's neovascularisation of the implant is a slow process that leads to its low viability. Thus, there is great interest in creating a vascular differentiation protocol for hESC structures to reduce the time required for vascularity and implant survival. Initially we used a protocol for differentiation of hESC in EPC (Endothelial Progenitor Cells) [234], where initially induction is done to mesoderm and in a second stage, which depends exclusively on the action of VEGF, commitment to EPC takes place. In this context, we identified the intradermal subpopulation that is a target of the VEGF and leads to the creation of EPC. To this end, we developed a simple, effective and rapid in vitro approach, where in the absence of feeder cells and low serum content, we caused the differentiation of human pluripotent stem cells-hPSC (hESC and hiPSC) into distinct populations and SMC (contractile and synthetic hPSC-SMC). These populations were extensively characterized by their phenotype (expression of CD44, CD73, CD105, NG2, PDGFRβ markers and contractile proteins) and their functions as hPSC-SMC. They were phenotypically and functionally stable for at least 8 generations and could integrate, stabilize and inhibit vascular network regression during co-culture with EC in vitro. Next, using a methylcellulose-based system, we created 3D spheroids consisting of EC/hPSC-SMC (vascular organoids), which were extensively phenotypically characterized. In addition, vascular organs functioned as starting points for capillary germination in vitro, and their in vivo implantation led to the rapid formation of a complex functional vascular network. Finally, we investigated the angiogenic potential of these vascular organelles during their incorporation into hydrogels consisting of defined components of the extracellular substance (collagen / fibrinogen / fibronectin), which can be used as scaffolds in its field applications.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Markou, Maria
- Μάρκου, Μαρία
Subjects
dc:subject × 26- Αναγεννητική ιατρική
- Μηχανική ιστών
- Ανθρώπινα Επαναπρογραμματισμένα Βλαστικά Κύτταρα
- Αγγειοποίηση
- Αγγειογένεση
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Τοιχωματικά Κύτταρα
- Αγγειακά Λεία Μυϊκά Κύτταρα
- Σφαιροειδή
- Αγγειακά Οργανοειδή
- Regenerative medicine
- Tissue engineering
- Human Induced Pluripotent Stem Cells (hiPSC)
- Vasculogenesis
- Angiogenesis
- Vascular endothelial growth factor (VEGF)
- Mural Cells
- Vascular Smooth Muscle Cells (vSMC)
- Spheroids
- Vascular Organoids
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, άλλοι τομείς
- Health Sciences
- Medical and Health Sciences
- Health sciences, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49557